Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isotonic sodium chloride solution, commonly known as normal saline (0.9% NaCl), is a sterile, non-pyrogenic solution of sodium chloride in water. In the context of the clinical trial conducted by Bnai Zion Medical Center for polymyalgia rheumatica (NCT04141280), it is utilized as an intramuscular placebo control. The trial evaluates the efficacy of a single micro-pulse steroid injection (betamethasone dipropionate and betamethasone sodium phosphate) as an induction therapy alongside standard oral prednisone. As a placebo, the isotonic sodium chloride solution serves as a neutral comparator to establish the baseline effect and safety profile of the experimental treatment arm, lacking active anti-inflammatory or immunomodulatory properties for the treatment of polymyalgia rheumatica.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isotonic sodium chloride solution.